Jed Black Selected Research

Sleep Initiation and Maintenance Disorders (Insomnia)

8/2017	Efficacy and safety of almorexant in adult chronic insomnia: a randomized placebo-controlled trial with an active reference.
2/2017	Dual Orexin Receptor Antagonist, Almorexant, in Elderly Patients With Primary Insomnia: A Randomized, Controlled Study.
7/2016	Effect of Oral JZP-110 (ADX-N05) on Wakefulness and Sleepiness in Adults with Narcolepsy: A Phase 2b Study.
6/2007	Long-term nightly treatment with indiplon in adults with primary insomnia: results of a double-blind, placebo-controlled, 3-month study.
5/2006	Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults.
1/2006	gamma-Hydroxybutyrate/sodium oxybate: neurobiology, and impact on sleep and wakefulness.
10/2002	The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jed Black Research Topics

Disease

39	Narcolepsy 12/2023 - 10/2002
17	Cataplexy 12/2023 - 10/2002
16	Disorders of Excessive Somnolence (Hypersomnia) 12/2023 - 10/2002
15	Sleepiness 01/2022 - 11/2004
10	Obstructive Sleep Apnea 01/2022 - 10/2002
7	Sleep Initiation and Maintenance Disorders (Insomnia) 08/2017 - 10/2002
5	Headache (Headaches) 01/2019 - 05/2006
5	Nausea 01/2019 - 05/2006
4	Idiopathic Hypersomnia 10/2023 - 01/2022
4	Sleep Apnea Syndromes (Sleep Apnea) 01/2019 - 01/2003
3	Nasopharyngitis 01/2019 - 01/2018
2	Sleep Wake Disorders 01/2022 - 10/2002
2	Muscle Weakness 01/2022 - 09/2005
2	Dizziness (Lightheadedness) 01/2018 - 05/2006
1	Vomiting 01/2018
1	Enuresis 01/2018
1	Diarrhea 07/2016
1	Airway Obstruction (Choking) 02/2013
1	Apnea 10/2008
1	Bradycardia 01/2007
1	Syncope (Fainting) 01/2007
1	Migraine Disorders (Migraine) 05/2006
1	Body Weight (Weight, Body) 05/2006
1	Ulcerative Colitis 05/2006
1	Duodenal Ulcer (Curling's Ulcer) 05/2006
1	Mood Disorders (Mood Disorder) 05/2006
1	Fatigue 05/2006
1	Fibromyalgia (Fibrositis) 01/2006
1	Sleep Deprivation 09/2005
1	Type C Niemann-Pick Disease (Niemann Pick Disease, Type C) 10/2002
1	Nervous System Diseases (Neurological Disorders) 10/2002
1	Parkinson Disease (Parkinson's Disease) 10/2002
1	Prader-Willi Syndrome (Syndrome, Prader-Willi) 10/2002
1	Restless Legs Syndrome (Restless Legs) 10/2002

Drug/Important Bio-Agent (IBA)

29	Sodium Oxybate (gamma Hydroxybutyrate)FDA Link 12/2023 - 11/2004
10	solriamfetolIBA 01/2022 - 07/2016
8	Modafinil (Provigil)FDA Link 01/2020 - 01/2003
5	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2020 - 02/2017
5	OrexinsIBA 08/2017 - 10/2002
4	Dopamine (Intropin)FDA LinkGeneric 01/2020 - 01/2019
3	SolutionsIBA 01/2022 - 01/2018
2	NexusIBA 01/2021 - 01/2021
2	almorexantIBA 08/2017 - 02/2017
1	SodiumIBA 12/2023
1	Antidepressive Agents (Antidepressants)IBA 01/2022
1	BenzodiazepinesIBA 02/2017
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 02/2017
1	Anti-Anxiety Agents (Anxiolytics)IBA 02/2017
1	Orexin Receptor AntagonistsIBA 02/2017
1	Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA 02/2017
1	Serotonin (5 Hydroxytryptamine)IBA 02/2017
1	Hypnotics and Sedatives (Sedatives)IBA 02/2017
1	Oxygen (Dioxygen)IBA 10/2008
1	indiplonIBA 06/2007
1	Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone (FCCP)IBA 02/2007
1	Psychotropic Drugs (Psychoactive Drugs)IBA 10/2002
1	HLA-DQB1 antigen (HLA DQB1)IBA 10/2002
1	HLA-DQ Antigens (HLA-DQ)IBA 10/2002

Therapy/Procedure

10	Therapeutics 01/2022 - 12/2002
3	Continuous Positive Airway Pressure 09/2013 - 05/2006
1	Oral Administration 02/2017
1	Plasmapheresis 09/2005